Our pipeline
澳门第一赌城在线娱乐有一个令人兴奋和平衡的管道，以伟大的科学为基础.
Home / Our therapy areas / Our pipeline
Latest quarterly updates
澳门第一赌城在线娱乐的产品线在临床开发的不同阶段形成了强大的研究性治疗组合.
167
projects in our pipeline
14
new molecular entities in our late-stage pipeline
3
new molecular entities under review
第三阶段/LCM项目:指的是第二/第三阶段的关键资产, 或者已经提交监管部门批准的, 并且可能包括现在在一个或多个主要市场推出的资产(在所有适用的主要市场推出时删除).
Oncology (as of 9 November 2023)
Phase I
Phase I
Phase II
Phase II
Phase III
Phase III
LCM Projects
LCM Projects
心血管、肾脏及代谢(截至2023年11月9日)
Phase I
Phase I
Phase II
Phase II
Phase III
Phase III
LCM Projects
Respiratory & Immunology (as of 9 November 2023)
Phase I
Phase I
Phase II
Phase III
Phase III
LCM Projects
LCM Projects
Rare Disease (as of 9 November 2023)
Phase I
Phase I
Phase II
Phase II
Phase III
Phase III
LCM Projects
Vaccine & Immune therapies (as of 28 July 2023)
Phase I
Phase I
Phase II
Phase II
Phase III
LCM Projects
LCM Projects
Other (as of 9 November 2023)
Phase I
Phase II
Phase III
Phase III
LCM Projects
LCM Projects
Removed since last quarter
Veeva ID: Z4-57208
Date of preparation: August 2023